ConductScience.org, home

Paper38482003

IL-17A inhibitors alleviate Psoriasis with concomitant restoration of intestinal/skin microbiota homeostasis and altered microbiota function.

Zhao H and 7 others. Front Immunol, 2024. Cited by 23 papers, by iCite.

Cite this record

ConductScience Library. IL-17A inhibitors alleviate Psoriasis with concomitant restoration of intestinal/skin microbiota homeostasis and altered microbiota function. Papers, record 38482003. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38482003

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
IL-17A inhibitors alleviate Psoriasis with concomitant restoration of intestinal/skin microbiota homeostasis and altered microbiota function.
PubMed
Journal
Front Immunol
PubMed
Year
2024
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
23
iCite
Relative citation ratio, by iCite
5.07, provisional
iCite
Revised in PubMed
2024-04-10
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zhao HHuixia
2Shang LLili
3Zhang YYuting
4Liang ZZhaojun
5Wang NNan
6Zhang QQian
7Gao CChong
8Luo JJing

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Gastrointestinal MicrobiomeMajor topic
PsoriasisMajor topic
MicrobiotaMajor topic
Animals
Mice
Humans
Interleukin-17
Longitudinal Studies
Case-Control Studies
RNA, Ribosomal, 16S
Bacteria
Homeostasis

Source PubMed

Download CSV of topics

References101

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
131549347Gut Microbiome in Psoriasis is Perturbed Differently During Secukinumab and Ustekinumab Therapy and Associated with Response to Treatment.Clin Drug Investig2019https://conductscience.org/library/papers/31549347PubMed
232415989Pathological role of excessive DNA as a trigger of keratinocyte proliferation in psoriasis.Clin Exp Immunol2020https://conductscience.org/library/papers/32415989PubMed
322571556A comparative study of childhood psoriasis and atopic dermatitis and greater understanding of the overlapping condition, psoriasis-dermatitis.Australas J Dermatol2012https://conductscience.org/library/papers/22571556PubMed
429559344Longitudinal Study of the Psoriasis-Associated Skin Microbiome during Therapy with Ustekinumab in a Randomized Phase 3b Clinical Trial.J Invest Dermatol2018https://conductscience.org/library/papers/29559344PubMed
523521130Is chronic plaque psoriasis triggered by microbiota in the skin?Br J Dermatol2013https://conductscience.org/library/papers/23521130PubMed
635214702The Gut Microbiome in Psoriasis and Crohn's Disease: Is Its Perturbation a Common Denominator for Their Pathogenesis?Vaccines (Basel)2022https://conductscience.org/library/papers/35214702PubMed
732545459Gut Microbiome in Psoriasis: An Updated Review.Pathogens2020https://conductscience.org/library/papers/32545459PubMed
832860635Diversity analysis of gut microbiota between healthy controls and those with atopic dermatitis in a Chinese population.J Dermatol2021https://conductscience.org/library/papers/32860635PubMed
928012235A safflower oil based high-fat/high-sucrose diet modulates the gut microbiota and liver phospholipid profiles associated with early glucose intolerance in the absence of tissue inflammation.Mol Nutr Food Res2017https://conductscience.org/library/papers/28012235PubMed
1023685373Bifidobacterium fermented milk and galacto-oligosaccharides lead to improved skin health by decreasing phenols production by gut microbiota.Benef Microbes2014https://conductscience.org/library/papers/23685373PubMed
1134755891PASI vs PO-PASI: Patient-Oriented PASI (PO-PASI) is comparable to clinician score PASI.Australas J Dermatol2022https://conductscience.org/library/papers/34755891PubMed
1234233192Gut microbiota-derived short-chain fatty acids regulate IL-17 production by mouse and human intestinal γδ T cells.Cell Rep2021https://conductscience.org/library/papers/34233192PubMed
1322699609Structure, function and diversity of the healthy human microbiome.Nature2012https://conductscience.org/library/papers/22699609PubMed
1429454560Bioactive Lipid Mediator Profiles in Human Psoriasis Skin and Blood.J Invest Dermatol2018https://conductscience.org/library/papers/29454560PubMed
1530238519Intestinal microbiota profiling and predicted metabolic dysregulation in psoriasis patients.Exp Dermatol2018https://conductscience.org/library/papers/30238519PubMed
1610894962Apoptosis in established and healing psoriasis.Dermatology2000https://conductscience.org/library/papers/10894962PubMed
1727050731New insights into the role of T cells in pathogenesis of psoriasis and psoriatic arthritis.Autoimmunity2016https://conductscience.org/library/papers/27050731PubMed
1832835590Gut microbes from the phylogenetically diverse genus Eubacterium and their various contributions to gut health.Gut Microbes2020https://conductscience.org/library/papers/32835590PubMed
1936145063Short Chain Fatty Acids (SCFAs) Are the Potential Immunomodulatory Metabolites in Controlling Staphylococcus aureus-Mediated Mastitis.Nutrients2022https://conductscience.org/library/papers/36145063PubMed
2037207807Resolved Psoriasis with Abundant Oleic Acid in Stratum Corneum Exhibits Lower T-Cell-Driven IL-17 Signature.J Invest Dermatol2023https://conductscience.org/library/papers/37207807PubMed

See all 101 referencesDownload CSV of references

Cited by13

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 23 citations.

PMIDTitleJournalYearIn PapersSource
42496842Therapeutic potential of polygonatum polysaccharides in modulating gut microbiota and alleviating psoriasis-like inflammation in a mouse model.Mol Cell Biochem2026https://conductscience.org/library/papers/42496842PubMed
42151128Gut microbiota-induced perturbation in bile acids alter keratinocyte lipid metabolism via FXR-NQO1 signaling in psoriasis.Nat Commun2026https://conductscience.org/library/papers/42151128PubMed
41900935Pharmacomicrobiomics in Psoriasis: Microbiome-Drug Interactions Across Systemic Treatments.Life (Basel)2026https://conductscience.org/library/papers/41900935PubMed
41795861The Emerging Role of Gut Microbiota in Inflammatory Skin Diseases: A Systematic Review.Exp Dermatol2026https://conductscience.org/library/papers/41795861PubMed
41487796Efficacy of Probiotic Supplementation in the Management of Psoriasis: A Systematic Review.Cureus2025https://conductscience.org/library/papers/41487796PubMed
41321593Clinical Treatment and Clinical Application Research Progress of Psoriasis and Intestinal Microbiota Dysbiosis.Clin Cosmet Investig Dermatol2025https://conductscience.org/library/papers/41321593PubMed
41302127Anti-IL-17 and Anti-IL-23 Therapies Modulate Serum Biomarkers of Intestinal Dysbiosis and Oxidative Stress Linked to Cardiovascular Risk in Patients with Psoriasis.Life (Basel)2025https://conductscience.org/library/papers/41302127PubMed
40708005IL-17A inhibitors modulate skin microbiome in psoriasis: implications for microbial homeostasis.J Transl Med2025https://conductscience.org/library/papers/40708005PubMed
40333159Characterization of the Gut Microbiota in Patients with Psoriasis: A Systematic Review.Pathogens2025https://conductscience.org/library/papers/40333159PubMed
40161116Emerging Novel Therapies for the Treatment of Psoriasis: A Narrative Review.Cureus2025https://conductscience.org/library/papers/40161116PubMed
39582772The interplay between epidermal barrier distribution, microbiota composition, and immune infiltrate defines and stratifies psoriasis patients and is associated with disease severity.J Transl Autoimmun2024https://conductscience.org/library/papers/39582772PubMed
39328313The efficacy and safety of probiotics in the adjuvant treatment of psoriasis: a systematic review and meta-analysis of randomized controlled trials.Front Med (Lausanne)2024https://conductscience.org/library/papers/39328313PubMed
39170985Gut microbiota and psoriasis: pathogenesis, targeted therapy, and future directions.Front Cell Infect Microbiol2024https://conductscience.org/library/papers/39170985PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
IL17A3605PubTator's text mininghttps://conductscience.org/library/genes/3605

Source NCBI Gene

Download CSV of genes

Data1

The data bank entries PubMed's record names. Trial numbers are under Trials.

Data bankAccession
SRA1078442

Source SRA

Download CSV of data

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/38482003

GET https://conductscience.org/api/papers/v1/38482003/references?page=2